Evidence map›Paper›PMID 7935384›Full record

ArticleMolecular and cellular biology1994

The Ras/Raf signaling pathway is required for progression of mouse embryos through the two-cell stage.

N Yamauchi, A A Kiessling, G M Cooper

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Transcriptional Regulation of the First Cell Fate Decision.Journal of developmental biology & regenerative medicine · 2017
    Article
  4. Kras Is Critical for B Cell Lymphopoiesis.Journal of immunology (Baltimore, Md. : 1950) · 2016
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

N YamauchiDivision of Molecular Genetics, Dana-Farber Cancer Institute, Boston, MA 02115.
A A Kiessling
G M Cooper
Dana-Farber Cancer Institute · US

Funding

PROTO-ONCOGENES IN GAMETOGENESIS AND EARLY DEVELOPMENTR01HD026594 · NICHD · DANA-FARBER CANCER INSTITUTE · PI COOPER, GEOFFREY M · 1989 to 1999
–
NICHD NIH HHS HD26594
6 · The paper itself

Abstract

We have used microinjection of antisense oligonucleotides, monoclonal antibody, and the dominant negative Ras N-17 mutant to interfere with Ras expression and function in mouse oocytes and early embryos. Microinjection of either ras antisense oligonucleotides or anti-Ras monoclonal antibody Y13-259 did not affect normal progression of oocytes through meiosis and arrest at metaphase II. However, microinjection of fertilized eggs with constructs expressing Ras N-17 inhibited subsequent development through the two-cell stage. The inhibitory effect of Ras N-17 was overcome by simultaneous injection of a plasmid expressing an active raf oncogene, indicating that it resulted from interference with the Ras/Raf signaling pathway. In contrast to the inhibition of two-cell embryo development resulting from microinjection of pronuclear stage eggs, microinjection of late two-cell embryos with Ras N-17 expression constructs did not affect subsequent cleavages and development to morulae and blastocysts. It thus appears that the Ras/Raf signaling pathway, presumably activated by autocrine growth factor stimulation, is specifically required at the two-cell stage, which is the time of transition between maternal and embryonic gene expression in mouse embryos.

Indexed as

Signal TransductionAnimalsAntibodies, MonoclonalBase SequenceBlastocystCell DivisionCleavage Stage, OvumGene Expression RegulationMeiosisMiceMolecular Sequence DataMorulaMutationOligonucleotides, AntisenseOncogene Protein p21(ras)Oncogene Proteins v-rafAntibodies, MonoclonalOligonucleotides, AntisenseOncogene Protein p21(ras)Oncogene Proteins v-rafRetroviridae Proteins, Oncogenic

Identifiers

PMID7935384
PMCPMC359195
OpenAlexW1888777832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.